Opposite effect of fluticasone and salmeterol on fibronectin and tenascin‐C expression in primary human lung fibroblasts

Martin Degen, Stéphanie Goulet, Jacqueline Ferralli, Michael Roth, M. Tamm, Ruth Chiquet‐EhrismannClinical 2009 · DOI

Abstract

Our results indicate that standard therapies for inflammatory lung disorders influence ECM protein composition and relative expression levels. In contrast to corticosteroids, LABA did not significantly alter the expression of tenascin-C and fibronectin in cultures of primary human lung fibroblasts.
BibTeX
@inproceedings{degen2009opposite,
  author = {Martin Degen and Stéphanie Goulet and Jacqueline Ferralli and Michael Roth and M. Tamm and Ruth Chiquet‐Ehrismann},
  title = {{Opposite effect of fluticasone and salmeterol on fibronectin and tenascin‐C expression in primary human lung fibroblasts}},
  booktitle = {Clinical},
  year = {2009},
  doi = {10.1111/j.1365-2222.2009.03220.x},
}

Loading related content...

Figure